Hemodiafiltration Versus Hemodialysis in Older People

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age85+
SponsorAUB Santé

About this trial

This study will compare the impact of two hemodialysis techniques on fatigue and post-dialysis recovery time in patients aged 85 years and older. These two techniques are high-flux hemodialysis (HD) and hemodiafiltration (HDF).

Patients will receive the treatment over two periods: if period 1 is HD then period 2 will be HDF. Every patient will be his/her own control, this is why it is called cross-over. Each period will last three months. Between the two periods, patients will receive a traditional low-flux hemodialysis.

These two techniques are widely used worldwide and their side-effects are well-known and do not put the patients at risk. HDF has been shown to improve survival in patients with a mean age of 58 years. But a previous study from the investigators' group showed that HDF causes a prolonged recovery time in older patients. This randomized trial aims to elucidate this question.

Eligibility criteria

Qualifiers

Signed and dated informed consent

Age >84 years

Diagnosed with kidney failure

On maintenance hemodialysis >3months

Disqualifiers

Patients with cognitive impairment (assessed with a mini-test if needed)

Hospitalized at inclusion

Have difficulties with French speaking

Terminally ill with life expectancy<3 months

Trial design

Treatments tested in this trial

  • High-flux hemodialysis
  • Hemodiafiltration

Treatment groups

62 Participants
are divided into 2 treatment groups

Sponsors and collaborators